Alterola Biotech

Alterola Biotech (ABTI) is a United Kingdom-based pharmaceutical company focused on developing medicines from cannabinoid and cannabinoid-like molecules. The company operates as a platform-based biotech firm with three primary business areas: development of regulated pharmaceuticals for human and animal health, production of active pharmaceutical ingredients and food-grade ingredients, and formulation and drug delivery optimization to improve bioavailability, solubility, and stability.

The company is currently traded on the over-the-counter market (OTCMKTS) under the ticker symbol ABTI. It is headquartered in Birkenhead, United Kingdom, and operates with a minimal staff of one employee as of the latest data. The company is led by David John Hitchcock as Chief Executive Officer and Timothy Paul Rogers as Executive Chairman, supported by a team of executive directors including Nathan Thompson (CFO), Colin G. Stott (COO), and Dominic Schiller (Chief IP Officer).